Instrumental Variable Methods for Censored Cost Data and an Application in Prosta

用于审查成本数据的工具变量方法及其在 Prosta 中的应用

基本信息

  • 批准号:
    8444529
  • 负责人:
  • 金额:
    $ 41.54万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-07-21 至 2014-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): There are many studies where the analytical task is to estimate the total costs over a defined period of time for a treatment group with a particular condition or chronic disease. These include cost of illness studies such as incremental or total lifetime costs for a disease, the components of cost effectiveness, and other forms of economic evaluation in health care. However, answering such questions requires addressing a range of statistical and econometric issues that include variable time periods of observation for individual patients, fluctuating costs over the course of the disease or treatment, the escalation of costs when the patient is dying and administrative censoring of data prior to the endpoint of interest (e.g. cure, death). These analytical obstacles are compounded by skewed cost data and the endogeneity of treatment decisions caused by self-selection into treatment based on expected idiosyncratic benefits, costs and risks of treatments. Our proposal will develop innovative methods to address each of these problems in a consolidated manner. The proposed work will advance four broad areas in the fields of cost analysis and economic evaluation in health studies. First, it will provide and validate a consistent method of estimating costs in a setting characterized by varying rates of spending over time, right censoring, and the escalation of expenditures commonly observed just before death. Second, it will bridge two large literatures on methods, one on modeling skewed cost data (with right censoring) and the other on the use of IV in the presence of treatment heterogeneity. Third, it can highlight the role that unobserved patient preferences and disease severity may have in generating treatment effect heterogeneity in the context of prostate cancer. Lastly, this work has a high likelihood of generating new information about the comparative cost estimates in prostate cancer which can serve as important inputs into cost-effectiveness and other policy analyses.
描述(由申请人提供):在许多研究中,分析任务是估计特定条件或慢性疾病治疗组在规定时间内的总成本。其中包括疾病成本研究,如疾病的增量成本或总生命周期成本,成本效益的组成部分,以及卫生保健中的其他形式的经济评估。然而,回答这些问题需要解决一系列统计和计量经济学问题,其中包括对个别患者观察的可变时间段、疾病或治疗过程中的波动成本、患者死亡时成本的上升以及在感兴趣的终点(例如治愈、死亡)之前对数据的行政审查。这些分析障碍由于成本数据的偏差和治疗决策的内生性而变得更加复杂,这些决策是由基于预期的特殊效益、成本和治疗风险的自我选择造成的。我们的建议将发展创新的方法,以综合的方式解决每一个问题。拟议的工作将推动保健研究中的成本分析和经济评价四个广泛领域。首先,它将提供并验证一种一致的估算成本的方法,这种方法的特点是随着时间的推移而变化的支出率,正确的审查,以及通常在死亡前观察到的支出的增加。其次,它将连接两个关于方法的大型文献,一个是关于扭曲成本数据的建模(右审查),另一个是关于在存在治疗异质性的情况下使用IV。第三,它可以突出未被观察到的患者偏好和疾病严重程度可能在前列腺癌治疗效果异质性中所起的作用。最后,这项工作很有可能产生关于前列腺癌比较成本估算的新信息,这可以作为成本效益和其他政策分析的重要投入。

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Estimating Decision-Relevant Comparative Effects Using Instrumental Variables.
  • DOI:
    10.1007/s12561-011-9033-6
  • 发表时间:
    2011-09
  • 期刊:
  • 影响因子:
    1
  • 作者:
    Basu, Anirban
  • 通讯作者:
    Basu, Anirban
Long-term costs of introducing HPV-DNA post-treatment surveillance to national cervical cancer screening in Ireland.
Highlighting differences between conditional and unconditional quantile regression approaches through an application to assess medication adherence.
  • DOI:
    10.1002/hec.2927
  • 发表时间:
    2013-09
  • 期刊:
  • 影响因子:
    2.1
  • 作者:
    Borah, Bijan J.;Basu, Anirban
  • 通讯作者:
    Basu, Anirban
Welfare implications of learning through solicitation versus diversification in health care.
通过招揽学习与医疗保健多元化对福利的影响。
  • DOI:
    10.1016/j.jhealeco.2015.04.001
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    3.5
  • 作者:
    Basu,Anirban
  • 通讯作者:
    Basu,Anirban
Are Elderly Patients With Clinically Localized Prostate Cancer Overtreated? Exploring Heterogeneity in Survival Effects.
  • DOI:
    10.1097/mlr.0000000000000260
  • 发表时间:
    2015-01
  • 期刊:
  • 影响因子:
    3
  • 作者:
    Basu A;Gore JL
  • 通讯作者:
    Gore JL
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANIRBAN BASU其他文献

ANIRBAN BASU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANIRBAN BASU', 18)}}的其他基金

Empowering the Annual Health Econometrics Workshop
赋能年度健康计量经济学研讨会
  • 批准号:
    9768968
  • 财政年份:
    2017
  • 资助金额:
    $ 41.54万
  • 项目类别:
Value of Information Methods for NHLBI Trials
NHLBI 试验的信息方法的价值
  • 批准号:
    9050702
  • 财政年份:
    2015
  • 资助金额:
    $ 41.54万
  • 项目类别:
Empowering the Annual Health Econometrics Workshop
赋能年度健康计量经济学研讨会
  • 批准号:
    8709046
  • 财政年份:
    2014
  • 资助金额:
    $ 41.54万
  • 项目类别:
Empowering the Annual Health Econometrics Workshop
赋能年度健康计量经济学研讨会
  • 批准号:
    9023509
  • 财政年份:
    2014
  • 资助金额:
    $ 41.54万
  • 项目类别:
Empowering the Annual Health Econometrics Workshop
赋能年度健康计量经济学研讨会
  • 批准号:
    8231253
  • 财政年份:
    2012
  • 资助金额:
    $ 41.54万
  • 项目类别:
Empowering the Annual Health Econometrics Workshop
赋能年度健康计量经济学研讨会
  • 批准号:
    8446920
  • 财政年份:
    2012
  • 资助金额:
    $ 41.54万
  • 项目类别:
Instrumental Variable Methods for Censored Cost Data and an Application in Prosta
用于审查成本数据的工具变量方法及其在 Prosta 中的应用
  • 批准号:
    8028216
  • 财政年份:
    2011
  • 资助金额:
    $ 41.54万
  • 项目类别:
Instrumental Variable Methods for Censored Cost Data and an Application in Prosta
用于审查成本数据的工具变量方法及其在 Prosta 中的应用
  • 批准号:
    8305510
  • 财政年份:
    2011
  • 资助金额:
    $ 41.54万
  • 项目类别:
A Comprehensive Probabilistic-Micro-Simulation Model to Assess Cost-Effectiveness
用于评估成本效益的综合概率微观模拟模型
  • 批准号:
    8035726
  • 财政年份:
    2010
  • 资助金额:
    $ 41.54万
  • 项目类别:
Advancing Instrumental Variable Methods in Comparative Effectiveness Research
推进比较有效性研究中的工具变量方法
  • 批准号:
    8036881
  • 财政年份:
    2010
  • 资助金额:
    $ 41.54万
  • 项目类别:

相似海外基金

Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 41.54万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
  • 批准号:
    10100360
  • 财政年份:
    2024
  • 资助金额:
    $ 41.54万
  • 项目类别:
    Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
  • 批准号:
    24K04974
  • 财政年份:
    2024
  • 资助金额:
    $ 41.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
  • 批准号:
    2312319
  • 财政年份:
    2023
  • 资助金额:
    $ 41.54万
  • 项目类别:
    Standard Grant
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
  • 批准号:
    23K01686
  • 财政年份:
    2023
  • 资助金额:
    $ 41.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
  • 批准号:
    23K01692
  • 财政年份:
    2023
  • 资助金额:
    $ 41.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
  • 批准号:
    23K01695
  • 财政年份:
    2023
  • 资助金额:
    $ 41.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
  • 批准号:
    23K01713
  • 财政年份:
    2023
  • 资助金额:
    $ 41.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
  • 批准号:
    23K01715
  • 财政年份:
    2023
  • 资助金额:
    $ 41.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
  • 批准号:
    10585388
  • 财政年份:
    2023
  • 资助金额:
    $ 41.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了